Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating these receptors, https://joanwqcu045407.dreamyblogs.com/36614318/tirzepatide-a-promising-new-treatment-for-obesity